Method of treatment of macular degeneration
US5632984A · kind A · utility
89Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 28, 1994 |
| Grant date | May 27, 1997 |
| Priority date | — |
| Expiry date | Sep 28, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/1647
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Intraocular administration of drugs such as .alpha.-2a interferon is employed in the treatment of age-related macular degeneration. Intraocular administration obviates the side effects associated with systemic administration, concentrates the drug at the site of the disease, and, where microcapsules are employed, provides continuous, long-lasting treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.